Relmada Therapeutics Inc 2024年度报告

FORM10-K ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year endedDecember 31,2024 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number:000-55347 Relmada Therapeutics, Inc.(Exact name of registrant as specified in its charter) Nevada45-5401931(State or other jurisdiction of(I.R.S. Employer incorporation or organization)Identification No.) 2222 Ponce de Leon Blvd.,Floor 3Coral Gables,FL33134(Address of principal executive offices) (Zip Code) (786)629 1376(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on whichregistered TheNASDAQGlobal Select Market Securities registered pursuant to section 12(g) of the Act:None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐No☒ Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Accelerated filer☐Non-accelerated filer☒Smaller reporting company☒Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registeredpublic accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuantto §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☒ As of June 30, 2024 (the last business day of the registrant’s most recently completed second fiscal quarter), the aggregate marketvalue of the registrant’s common stock held by non-affiliates of the registrant was $89,007,030,based on the closing price on that dateas reported on the NASDAQ. As of March 25, 2025, there were33,191,622shares of common stock, $0.001 par value per share, outstanding. Documents Incorporated by Reference Portions of the registrant’s definitive proxy statement for its 2025 Annual Meeting of Stockholders (the “Proxy Statement”), to be filedwithin 120 days of the registrant’s fiscal year ended December 31, 2024, are incorporated by reference in Part III of this Annual Reporton Form 10-K. Except with respect to information specifically incorporated by reference in this Annual Report on Form 10-K, theProxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K. TABLE OF CONTENTS Forward-Looking Statementsii 1.Business11A.Risk Factors161B.Unresolved Staff Comments381C.Cybersecurity382.Properties393.Legal Proceedings394.Mine Safety Disclosures39 PART II 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of EquitySecurities406.[Reserved]417.Management’s Discussion and Analysis of Financial Condition and Results of Operations417A.Quantitative and Qualitative Disclosures About Market Risk438.Financial Statements and Supplementary Data469.Changes in and Disagreements with Accountants on Accounting, and Financial Disclosure469A.Controls and Procedures469B.Other Information479C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections47